(Last updated 4/29/2014; last reviewed 4/29/2014)
Fewer than 200 babies with HIV are born each year in the United States.
The risk of mother-to-child transmission of HIV is low when:
Within 6 to 12 hours after birth, all babies born to women with HIV should receive an HIV medicine called zidovudine (brand name: Retrovir). In general, the babies receive zidovudine for 6 weeks. In certain situations, a baby may receive other HIV medicines in addition to zidovudine. The HIV medicine protects the babies from infection with any HIV that passed from mother to child during childbirth.
Babies born to women with HIV receive a medication called sulfamethoxazole/trimethoprim (brand name: Bactrim) after they have finished the 6-week course of zidovudine. Bactrim helps prevent Pneumocystis jiroveci pneumonia (PCP), which is a type of pneumonia that can develop in people with HIV. If HIV testing shows that a baby is not infected with HIV, there is no need for the baby to continue getting Bactrim and the medicine is stopped.
HIV testing is recommended at 14 to 21 days after birth, at 1 to 2 months, and again at 4 to 6 months. Testing should be done using an HIV test that looks directly for HIV in the blood (called a virologic HIV test). (In adults, the most commonly used HIV test is the HIV antibody test, which looks for HIV antibodies in the blood. For more information, read the AIDSinfo fact sheet on HIV Testing.) Test results from at least two HIV virologic tests are needed to determine a baby’s HIV status (HIV negative or HIV positive).
Fortunately, few babies in the United States are born with HIV because most pregnant women with HIV and their newborn babies receive HIV medicines. When testing shows that a baby is HIV positive, the baby is switched from zidovudine to a combination of HIV medicines (called antiretroviral therapy or ART). ART helps people with HIV live longer, healthier lives.
Because HIV can spread in breast milk, women with HIV who live in the United States should not breastfeed their babies. In the United States, infant formula is a safe and healthy alternative to breast milk.
There is evidence that HIV can spread in food that was previously chewed by a person infected with HIV. To be safe, babies should not be fed pre-chewed food.
Women should discuss with their health care providers whether to continue taking HIV medicines after childbirth. When making this decision, they take into account current recommendations on the use of HIV medicines. Treatment with HIV medicines is recommended for everyone infected with HIV to prevent HIV from advancing and to reduce the risk of sexual transmission of HIV . The recommendation is strongest for those with CD4 counts less than 350 cells/mm3 and those who have symptoms of HIV disease, high levels of HIV in their blood (HIV viral load), or certain conditions, such as AIDS or certain HIV-related illnesses or conditions.
A woman’s decision to continue or stop taking HIV medicines after childbirth will also depend on the following factors: